Nisa Investment Advisors, LLC Morphic Holding, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$26.12 - $34.07 $4,884 - $6,371	187 Added 54.05%	533 $18,000
Q1 2024 May 01, 2024	BUY	$26.64 - $40.31 $799 - $1,209	30 Added 9.49%	346 $12,000
Q4 2023 Jan 25, 2024	SELL	$19.95 - $31.0 $16,718 - $25,978	-838 Reduced 72.62%	316 $9,000
Q2 2023 Aug 11, 2023	SELL	$34.33 - $62.11 $5,836 - $10,558	-170 Reduced 12.84%	1,154 $66,000
Q3 2022 Nov 07, 2022	BUY	$22.23 - $33.37 $533 - $800	24 Added 1.85%	1,324 $37,000
Q2 2022 Aug 03, 2022	BUY	$19.74 - $43.01 $25,661 - $55,913	1,300 New	1,300 $28,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.